- Long-term Safety and Efficacy of Esketamine Nasal Spray Plus an Oral Antidepressant in Patients with Treatment-resistant Depression– an Asian Sub-group Analysis from the SUSTAIN-2 Study
-
Jeon HJ, Ju PC, Sulaiman AH, Aziz SA, Paik JW, Tan W, Bai D, Li CT
- KMID: 2526849
- Clin Psychopharmacol Neurosci.
- 2022 Feb;20(1):70-86.
- doi: 10.9758/cpn.2022.20.1.70
Objective: To evaluate the long-term safety and efficacy of intranasal esketamine in patients with treatment-resistant depression from the Asian subgroup of the SUSTAIN-2 study. Methods: SUSTAIN-2 was a phase 3, open-label,... -
- CITED
-
- Close
- SHARE
-
- Close
